[Featured Stock] SillaJen Plummets Over 10% as Prosecutors Intensify Investigation
[Asia Economy Reporter Minji Lee] Bio company Sillajen is experiencing a sharp decline. This appears to be due to the prosecution intensifying its investigation by requesting arrest warrants for former representatives of Sillajen amid suspicions of stock trading using undisclosed information.
According to the Korea Exchange at 11:11 AM on the 10th, Sillajen is trading at 11,600 KRW, down 11.11% from the previous session on the KOSDAQ market.
Hot Picks Today
If They Fail Next Year, Bonus Drops to 97 Million Won... A Closer Look at Samsung Electronics DS Division’s 600M vs 460M vs 160M Performance Bonuses
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- 25 Korean Vessels Remain in Hormuz... Government to Continue Additional Transit Talks with Iran
- Taiwan Unveils Bold Plan: Monthly Allowance for Children Under 18 to Tackle Low Birth Rate
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
On the same day, the Southern District Prosecutors' Office Financial Investigation Division 1 (Chief Prosecutor Seo Jeong-sik) announced that it has requested arrest warrants for former CEO Lee Yong-han (54) and former auditor Kwak Byung-hak (56) of Sillajen. They are suspected of using internal company information to sell large amounts of stock before the public disclosure of the suspension of clinical trials for Sillajen's immuno-oncology drug 'Pexavac,' thereby avoiding significant losses.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.